Furthermore, the level of FGF‐21 in the blood is strongly and independently associated with liver fat content, markers of liver cell death, and the severity of NAFLD in obese individuals (Francque et al., 2016; Qin et al., 2015). The gene discussed is FGF21; the disease is metabolic dysfunction-associated steatotic liver disease.